VAM
RGNX icon

Visium Asset Management’s Regenxbio RGNX Stock Holding History

Visium Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-204,342
Closed -$2.21M – 466
2016
Q1 		$2.21M Sell
204,342
-49,581
-20% -$635K 0.04% 377
2015
Q4 		$4.21M Hold
253,923
– – 0.06% 303
2015
Q3 		$5.59M Buy
+253,923
New +$6.48M 0.08% 274

Other funds holding RGNX

BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Visium Asset Management's RGNX Position: Q2 2016 in Review

Visium Asset Management sold out of Regenxbio (RGNX) in Q2 2016, closing a stake of 204,342 shares — an estimated $2.21M sold.

Visium Asset Management first reported a position in RGNX in Q3 2015 and held it in 3 quarters. The position peaked at $5.59M in Q3 2015. 69 funds tracked by Wall St. Rank hold RGNX as of Q2 2016.

  • Visium Asset Management reported no remaining Regenxbio position as of Q2 2016 after selling out during the quarter.
  • Visium Asset Management sold 204,342 Regenxbio shares in Q2 2016, an estimated $2.21M.
  • Visium Asset Management first reported a position in Regenxbio in Q3 2015 and held it in 3 quarters.
  • Visium Asset Management's Regenxbio position peaked at $5.59M in Q3 2015.
  • 69 funds tracked by Wall St. Rank held Regenxbio as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.